Department of Physiotherapy, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Department of Biomedical Sciences, Faculty of Health & Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa.
AIDS Care. 2022 Feb;34(2):173-181. doi: 10.1080/09540121.2021.1883513. Epub 2021 Feb 12.
The Human Immunodeficiency Virus (HIV) remains a major public health concern. Depression, anxiety and reduced self-efficacy are common psychological problems experienced by people living with HIV. We investigated the effects of a four-week, supervised aerobic exercise programme on depression, anxiety and self-efficacy of people living with HIV on HAART in Ibadan, Nigeria. A quasi-experimental design was used. Fifty-three eligible participants completed the study and only their data were analysed. The experimental subjects received aerobic exercise training for thirty minutes, three times per week for four weeks, alongside HAART, while control subjects were only on HAART. Depression, anxiety and self-efficacy scores were assessed at baseline and after the fourth week. Descriptive statistics of mean and standard deviation were used to summarise data, and inferential statistics of independent -test was used to compare data between groups. At the end of the aerobic exercise programme, there was significant improvement in depression ( < 0.001), anxiety ( < 0.001) and self-efficacy scores ( = 0.042) in the experimental group, compared to the control group. More attention should be given to the prevention and management of psychological problems in people living with HIV through the use of aerobic exercise.
人类免疫缺陷病毒(HIV)仍然是一个主要的公共卫生关注点。抑郁、焦虑和自我效能感降低是 HIV 感染者常见的心理问题。我们在尼日利亚伊巴丹调查了四周监督有氧运动方案对接受抗逆转录病毒治疗(HAART)的 HIV 感染者的抑郁、焦虑和自我效能感的影响。采用了准实验设计。53 名符合条件的参与者完成了研究,仅对他们的数据进行了分析。实验组接受了为期四周、每周三次、每次三十分钟的有氧运动训练,同时接受 HAART,而对照组仅接受 HAART。在基线和第四周后评估抑郁、焦虑和自我效能感评分。使用均值和标准差的描述性统计来总结数据,并使用独立样本 t 检验的推断统计来比较组间数据。在有氧运动方案结束时,实验组的抑郁( < 0.001)、焦虑( < 0.001)和自我效能感评分( = 0.042)显著改善,与对照组相比。应该更加关注通过有氧运动预防和管理 HIV 感染者的心理问题。